Plain-English translation of NCT07347028 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether injecting a steroid medication called triamcinolone acetonide into trigger points in the muscles around the knee works as well as injecting it directly into the knee joint itself. Both approaches are designed to reduce pain from knee arthritis. The study will follow patients for two years to see which method works better and lasts longer.
Many people with knee arthritis don't get enough relief from standard treatments like pills and physical therapy. Researchers believe injecting this medication into the tight muscle spots around the knee might be just as effective and easier to do than injecting into the joint itself, offering patients a simpler pain management option.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to receive either an injection into the trigger points in your leg muscles or an injection directly into your knee joint. Both groups receive the same medication to reduce inflammation. After your injection, you'll return for check-ups at 2 weeks, 4 weeks, 8 weeks, 12 weeks, and 24 weeks, where doctors will ask you about your pain levels and any side effects. The study lasts 2 years total, with the most frequent visits happening in the first 6 months.
AI-generated summary from trial data · Jun 1, 2026 · Not medical advice
China